Allogeneic hematopoietic stem cell transplantation for hematological malignancies from mismatched 9/10 HLA unrelated donors: Comparison with transplantations from 10/10 unrelated donors and HLA identical siblings. Leuk Lymphoma. 2014:1-16..
Current indications of allogeneic stem cell transplant in adults with acute myeloid leukemia. Bull Cancer. 2014..
Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels and their functional as well as prognostic roles in acute myeloid leukemia. Eur J Haematol. 2018.
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: long-term follow up of a phase III study. Am J Hematol. 2020.
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry. Leuk Res. 2021;111:106673.
Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia. World J Stem Cells. 2013;5(4):196-204.
A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia. Blood. 2020.
Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Leuk Lymphoma. 2016:1-4..
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood. 2022.
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood. 2015.